| Code | 6934C | ||||||||||
| MA number | 13/0049/18-S | ||||||||||
| Product Form: | con ijf 5x3 ml (5 ml amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | hameln pharma gmbh, Germany | ||||||||||
| Therapeutic Class: | 13 - ANTIARRYTHMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 07.02.2018 |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Amiodaron hameln 50 mg/ml_con ijf_06_2022.pdf
|
| PIL: |
PIL_Amiodaron hameln 50 mg/ml_con ijf_06_2022.pdf
|
| Safety feature | Yes |
| Data update: | 04.04.2023 |
